Fig. 5From: Pharmacokinetics and biodistribution of a novel anticancer thyrointegrin αvβ3 antagonist: triazole modified tetraiodothyroacetic acid conjugated to polyethylene glycol (P-bi-TAT)Typical LC-MS/MS for P-bi-TAT (5.7 min) and IS (5.2 min) in positive modeBack to article page